You would imagine that Anteo will be forced into referring back to " commercial in confidence" and not being able to confirm or deny market speculation
If these partners did not want to be named, it’s hard to imagine they’re going to change their mind at this point
Still I like the fact it’s out in the public domain now
The risks remain , perhaps like a bio-tech now , but one more successful trial and the potential upside is immense.
Ann: Commercialisation Milestone, page-243
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $113.3K | 5.852M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 3466117 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 57942 | 2 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |